Treatment of chronic inflammatory disease with polyvalent immunoglobulins
Patent 4676982 Issued on June 30, 1987. Estimated Expiration Date: 
August 4, 2006. Estimated Expiration Date is calculated based on simple USPTO term provisions. It does not account for terminal disclaimers, term adjustments, failure to pay maintenance fees, or other factors which might affect the term of a patent.
August 4, 2006. Estimated Expiration Date is calculated based on simple USPTO term provisions. It does not account for terminal disclaimers, term adjustments, failure to pay maintenance fees, or other factors which might affect the term of a patent.Patent ReferencesProduction of Protein A Patent #: 4617266 InventorAssigneeApplicationNo. 06/892655 filed on 08/04/1986US Classes:424/177.1, Reduced antigenicity, reduced ability to bind complement, or reduced numbers of activated complement components (e.g., free from aggregated, denatured, fragmented, or polymerized immunoglobulins; free from proteolytic enzymes, etc.)424/130.1, IMMUNOGLOBULIN, ANTISERUM, ANTIBODY, OR ANTIBODY FRAGMENT, EXCEPT CONJUGATE OR COMPLEX OF THE SAME WITH NONIMMUNOGLOBULIN MATERIAL530/387.1, Immunoglobulin, antibody, or fragment thereof, other than immunoglobulin antibody, or fragment thereof that is conjugated or absorbed530/390.5, Removing, dissociating, or preventing the formation of aggregated, denatured, fragmented, or polymerized immunoglobulin or antibody; or preventing or reducing complement fixation or binding; or reducing antigenicity; or removing, inactivating, or inhibiting contaminating plasma proteins (e.g., proteolytic enzymes, etc.)530/868INVOLVING AUTOIMMUNITY, ALLERGY, IMMEDIATE HYPERSENSITIVITY, DELAYED HYPERSENSITIVITY, IMMUNOSUPPRESSION, OR IMMUNOTOLERANCEExaminersPrimary: Schain, Howard E.Attorney, Agent or FirmInternational ClassesC07K 16/18 (20060101)A61K 38/00 (20060101) Foreign Application Priority Data1985-08-07 GBAbstractChronic inflammatory disease of the bowel, e.g. ulcerative colitis and Cr's disease, is treated by infusion of an intravenously injectable form of a polyvalent, intact immunoglobulin (IgG).Other References
|
| ||||||||||||||
